Review: taking Micardis and Lipitor together


Summary

Drug interactions are reported among people who take Micardis and Lipitor together. This review analyzes the effectiveness and drug interactions between Micardis and Lipitor. It is created by eHealthMe based on reports of 1,516 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Micardis and Lipitor >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Micardis

Micardis has active ingredients of telmisartan. It is often used in high blood pressure. (latest outcomes from Micardis 14,432 users)

Lipitor

Lipitor has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. (latest outcomes from Lipitor 130,075 users)

On Jul, 24, 2016

1,516 people who take Micardis, Lipitor are studied.


Number of reports submitted per year:

Micardis and Lipitor drug interactions.

Drug effectiveness over time:

Micardis:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 66.0% - (2 of 3 people)
  • 6 - 12 months: 44.0% - (4 of 9 people)
  • 1 - 2 years: 52.0% - (10 of 19 people)
  • 2 - 5 years: 70.0% - (12 of 17 people)
  • 5 - 10 years: 47.0% - (8 of 17 people)
  • 10+ years: 66.0% - (4 of 6 people)
  • not specified: 0.0% - (0 of 0 people)
Lipitor:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 25.0% - (1 of 4 people)
  • 6 - 12 months: 62.0% - (5 of 8 people)
  • 1 - 2 years: 12.0% - (1 of 8 people)
  • 2 - 5 years: 66.0% - (10 of 15 people)
  • 5 - 10 years: 68.0% - (13 of 19 people)
  • 10+ years: 70.0% - (7 of 10 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Micardis:
  • female: 50.0% - (12 of 24 people)
  • male: 59.0% - (28 of 47 people)
Lipitor:
  • female: 36.0% - (8 of 22 people)
  • male: 69.0% - (29 of 42 people)

Drug effectiveness by age:

Micardis:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 81.0% - (9 of 11 people)
  • 50-59: 54.0% - (13 of 24 people)
  • 60+: 48.0% - (17 of 35 people)
Lipitor:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 55.0% - (5 of 9 people)
  • 50-59: 56.0% - (13 of 23 people)
  • 60+: 59.0% - (19 of 32 people)

Most common drug interactions over time *:

< 1 month:
  • anorexia
  • dehydration
  • anaemia
  • liver disorder
  • myocardial infarction
  • nausea
  • acute myocardial infarction
  • blood pressure increased
  • cardiac failure congestive
  • cardiomyopathy
1 - 6 months:
  • pancytopenia
  • hepatitis acute
  • liver disorder
  • fatigue
  • gammopathy
  • polyneuropathy
  • raynaud's phenomenon
  • areflexia
  • arthralgia
  • cardiac disorder
6 - 12 months:
  • headache
  • dizziness
  • gammopathy
  • mitochondrial cytopathy
  • myopathy
  • polyneuropathy
  • raynaud's phenomenon
  • atrial fibrillation
  • blood creatine phosphokinase increased
  • cardiovascular disorder
1 - 2 years:
  • asthenia
  • bronchiolitis
  • fatigue
  • amnesia
  • hepatic function abnormal
  • liver disorder
  • pneumonia
  • jaundice
  • cognitive disorder
  • depression
2 - 5 years:
  • renal failure acute
  • rhabdomyolysis
  • bacteraemia
  • prostatitis
  • anaemia
  • blood immunoglobulin e increased
  • eosinophil count increased
  • duodenal ulcer perforation
  • gastric cancer
  • hyponatraemia
5 - 10 years:
  • rhabdomyolysis
  • decreased appetite
  • dehydration
  • metastases to bone
  • weight decreased
  • blood cholinesterase decreased
  • cough
  • drug eruption
  • liver disorder
  • fatigue
10+ years:
  • shortness of breath
  • cough
  • abdominal pain upper
  • constipation
  • drug ineffective
  • fatigue
  • hair loss
  • immune system disorder
  • myalgia
not specified:
  • fatigue
  • renal failure acute
  • myocardial infarction
  • headache
  • dizziness
  • nausea
  • dyspnoea
  • fall
  • asthenia
  • pyrexia

Most common drug interactions by gender *:

female:
  • fatigue
  • headache
  • nausea
  • myocardial infarction
  • renal failure acute
  • dizziness
  • pancytopenia
  • anaemia
  • gait disturbance
  • blood pressure increased
male:
  • asthenia
  • fatigue
  • renal failure acute
  • pyrexia
  • pneumonia
  • myocardial infarction
  • dizziness
  • dyspnoea
  • blood creatine phosphokinase increased
  • renal failure

Most common drug interactions by age *:

0-1:
  • heat exhaustion
  • hepatic function abnormal
20-29:
  • neurogenic bladder
  • bronchitis
  • conjunctivitis allergic
  • cytolytic hepatitis
  • gastroenteritis
  • gingivitis
  • immunosuppressant drug level increased
  • influenza
  • insomnia
  • iron deficiency anaemia
30-39:
  • blood creatinine increased
  • pyrexia
  • abscess
  • chronic allograft nephropathy
  • effusion
  • fluid retention
  • impaired healing
  • nephropathy
  • renal disorder
  • wound decomposition
40-49:
  • dizziness
  • loss of consciousness
  • blood creatine phosphokinase increased
  • death
  • hyperglycaemia
  • arthralgia
  • insomnia
  • anaphylactic shock
  • arteriosclerosis obliterans
  • asthenia
50-59:
  • fatigue
  • arthralgia
  • gait disturbance
  • anaemia
  • headache
  • pancytopenia
  • syncope
  • blood pressure increased
  • hepatitis acute
  • muscular weakness
60+:
  • renal failure acute
  • fatigue
  • asthenia
  • myocardial infarction
  • headache
  • dyspnoea
  • pyrexia
  • pneumonia
  • diarrhoea
  • nausea

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Micardis and Lipitor?

Can you answer these questions?

More questions for: Micardis, Lipitor

You may be interested in these reviews

More reviews for: Micardis, Lipitor

On eHealthMe, Micardis (telmisartan) is often used to treat high blood pressure. Lipitor (atorvastatin calcium) is often used to treat high blood cholesterol. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.